• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Montagu Private Equity LLP Completes Acquisition of the RTI Surgical OEM Business

Share:

July 27, 2020

Today, Montagu Private Equity LLP (‘Montagu’), a leading European private equity firm, announced the completion of its acquisition of the RTI Surgical OEM business. Following the acquisition, the OEM business will operate as a standalone company and retain the RTI Surgical name.

The new RTI Surgical will further its focus on driving innovation across its tissue, biologics and hardware platforms and strengthening its long standing collaboration with leading medical technology companies. The company will continue to distribute a comprehensive portfolio of surgical implants across multiple segments and commercial channels.

Olivier Visa, who has led the OEM business since 2017 will serve as President and Chief Executive Officer of RTI Surgical. “Today, with the support of Montagu, we are launching a new RTI Surgical, focused on employee development, customer intimacy and patient-centric innovation. Our service mindset will fuel our partnerships across all segments and channels we serve, deepening relationships with our customers and distributors to accelerate growth, serve more patients and maximize the gift of tissue donation. Montagu’s support, combined with our talented team, will unlock tremendous value for our existing and future partners. This is an inflexion point in our history that leverages the strength and resilience of our OEM business. Our future is supported by strong market trends toward increased outsourcing for industry leading design, development, processing and manufacturing services. We are tremendously thankful for the support from our partners, employees and distributors whose dedication and support have made this transition a very positive one,” Visa said.

Guillaume Jabalot, Director at Montagu, said: “As a strong, resilient business that is well-positioned to capitalize on accelerated growth opportunities, the OEM business is an excellent fit for Montagu’s investment strategy. We share a similar ambition for sustainable growth and look forward to working with Olivier and the team to support the business in this exciting next chapter, maintaining its ethos of exceptional service and innovation.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Pharma Companies Form Coalition to Fight FTC Antitrust OverhaulPharma Companies Form Coalition to Fight FTC Antitrust Overhaul
  • Backed by Major Health Plans, Carallel Raises $8.2M for Personalized Caregiver SupportBacked by Major Health Plans, Carallel Raises $8.2M for Personalized Caregiver Support
  • Philips & DoD Ink $10M Deal for AI-Wearable Disease DetectionPhilips & DoD Ink $10M Deal for AI-Wearable Disease Detection
  • Avista Healthcare Public Acquisition Corp. To Combine With Organogenesis Inc.Avista Healthcare Public Acquisition Corp. To Combine With Organogenesis Inc.
  • Thin-Film Electrodes Show Potential for Transforming NeurosurgeryThin-Film Electrodes Show Potential for Transforming Neurosurgery
  • Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and AbingworthSpruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and Abingworth
  • Cotiviti Launches Longitudinal Data Set in HealthcareCotiviti Launches Longitudinal Data Set in Healthcare
  • CVS Health Acquires Oak Street Health for $10.6B in CashCVS Health Acquires Oak Street Health for $10.6B in Cash

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications